𝔖 Bobbio Scriptorium

✦ LIBER ✦

Clinical safety and efficacy of clopidogrel-Implications of the clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE) study for future management of atherosclerotic disease

✍ Scribed by James J. Ferguson III; Edgar R. Gonzalez; William B. Kannel; Jeffrey W. Olin; Eric C. Raps

Book ID: 117322201
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 926 KB
Volume: 20
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(98)80029-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV44 COST EFFECTIVENESS OF CLOPIDOGREL

PCV44 COST EFFECTIVENESS OF CLOPIDOGREL TREATMENT VERSUS ASPIRIN TREATMENT IN SOUTH KOREAN PATIENTS WITH ATHEROTHROBOSIS: RESULTS OF THE CAPRIE (CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS) STUDY

✍ BM Yang; S Shin; JH Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

DIFFERENTIAL EFFECTS OF SMOKING ON LONG-

DIFFERENTIAL EFFECTS OF SMOKING ON LONG-TERM OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE TREATED WITH ASPIRIN OR CLOPIDOGREL: INSIGHTS FROM THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS TRIAL

✍ Jose Luis Ferreiro; Deepak Bhatt; Masafumi Ueno; Deborah Bauer; Dominick Angioli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Clinical Outcomes of Patients With Diabe

Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

✍ Arijit Dasgupta; Steven R. Steinhubl; Deepak L. Bhatt; Peter B. Berger; Mingyuan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 369 KB